ESSILORLUXOTTICA : UBS gives a Neutral rating
In a research note, UBS analyst Robert Krankowski has maintained his recommendation on the stock with a Neutral rating. The target price is unchanged and still at EUR 181.
Stay updated with breaking news from Robert Krankowski. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a research note, UBS analyst Robert Krankowski has maintained his recommendation on the stock with a Neutral rating. The target price is unchanged and still at EUR 181.
UBS analyst Robert Krankowski maintains his Neutral opinion on the stock. The target price is unchanged at EUR 181.
Analyst Robert Krankowski from UBS research considers the stock attractive and recommends it with a Buy rating.
In his latest research note, analyst Robert Krankowski confirms his recommendation. The broker UBS is keeping its Neutral rating. The target price is unchanged at EUR 181.
Initially Neutral on the company, UBS's analyst Robert Krankowski maintained his recommendation. The target price remains unchanged at EUR 181.